GILD
Gilead Sciences, Inc.$126.34+0.01% 1D· price as of Jun 30, 8:32 PM+17.39% over 1Y
Compare:GILD
Mkt Cap
$156.9B
P/E
17.2×
Fwd P/E
13.1×
PEG
2.14
P/B
6.7×
P/S
5.3×
EV/EBITDA
11.5×
Beta
0.33
Div Yield
2.6%
Payout
43.4%
ROE
43.4%
Net Margin
31.0%
Short % Flt
1.9%
Inst. Own
92.2%
52-wk low $107.75$126.3452-wk high $157.29
+17.3% above low-19.7% from high
Seasonality — avg monthly return
Strongest Oct 7.7% · weakest Apr -4.2%Jan
+3.7
Feb
-1.3
Mar
-0.0
Apr
-4.2
May
+1.9
Jun
+0.2
Jul
+1.4
Aug
+3.5
Sep
-0.9
Oct
+7.7
Nov
+5.0
Dec
+1.2
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Gilead Sciences, Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
GILD — recent news
Loading headlines…
Quality scorecard
vs Biotechnology · 8 peers · percentile rank
79 / 100
Strong
ROIC21.3%
100
ROE37.5%
86
Gross margin78.8%
57
Operating margin39.7%
100
FCF yield6.0%
86
Net debt / EBITDA1.3×
43
Percentile vs 8 Biotechnology peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.